You are Trying to View a Free Article
Daily News You Can't Find Anywhere ElseIndia's Pharma Majors See Huge HCQ Export Potential, an Industrial Info Market Brief
Industry Segment: Market Brief | Word Count: 179 Words
Attachment: India HCQ 0420
India's leading pharmaceutical companies, including Zydus Cadila and Ipca Laboratories, have started increasing production of the antimalarial drug hydroxychloroquine (HCQ), which has been touted by U.S. President Donald Trump and others as a potential treatment for COVID-19. Its status in regards to COVID-19 remains a topic of debate among health professionals.
Subscribe Now! All Fields Required...
Related Articles
- Woodside Awards Technip Offshore Tieback Contract, an Industrial Info Marke...
- Finland's Mining Sector Hosts $9.9 Billion in Projects, an Industrial Info ...
- South Korea's Chemical Producers to Authorize $2.5 Billion in Investments t...
- Africa to Spend $104 Million in Industrial Organic and Industrial Inorganic...
- India's ONGC Proceeds with Mumbai High PRP-7 Offshore Project, an Industria...
- Current Economic Indicators
- Free Daily Industrial Articles
- Monthly Industrial Newsletter
- IIR's Disaster Impact Tracker
All Members Receive the Following Free Resources:
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
